IL6 and COVID-19: Interleukin-6 (IL-6), as a mediator of the acute-phase inflammatory response in sepsis, ARDS, and COVID-19, is a key player in the ‘cytokine storm’ often observed and associated with ACB hyperpermeability [13,14].